Diane Côté - MEDTEQ

Technologies of the future –
Health of tomorrow
Diane Côté
CEO of MEDTEQ
Presented by Diane Côté, CEO of
Presented by Diane Côté, CEO of
Medical Technology - Canada
• Medical device+ market: $6.7 billion (2% of the global
market) in 2014
% of Sales in Canada (2014)
27%
20%
18%
8%
12%15%
Diagnostics imaging
Consummables
Patient aids
Orthopedics and prosthetics
Dental products
Others
• Manufacturing:
•
•
Lowest business cost structure and tax burden among the
G7
13.1% savings compared to US (KPMG)
• Canada also ranks 3rd in the world for the number of sites
for active clinical trials of medical devices
. 1,700+ medtech companies
• Main locations: Ontario (52%), Quebec (37%) and British
Columbia (8%) (2011)
Presented by Diane Côté, CEO of
Québec-Ontario Corridor
Ontario
Quebec
• The largest medical devices producer in
Canada - with annual sales over $2
billion.
• Annual medtech purchasing: 1,8 B $
• 75% of Quebec jobs in health technologies
are located in Greater Montreal.
• Ontario producers export approximately
90% of products made.
• Approximately 240 complementary
service providers, including industrial
design, plastics, electronics, textiles,
metals and public research organizations,
Quebec-Ontario Life Sciences corridor
are also present in the region
The second largest in North America in terms of
number of life sciences companies and brings a critical
mass of:
• More than 1,100 companies
• 66 000 qualified people
• 490 undergraduate and graduate programs in
biological and biomedicine sciences
• Produces the majority of Canadian sales and
exports in life sciences
• Access to the majority of Canadian venture capital.
Presented by Diane Côté, CEO of
Medical Technology expertise - Canada
Vancouver
Image Analysis
Edmonton & Calgary
Micro- and
Nanotechnology
Halifax
Brain
Winnipeg
Imaging
Toronto: Brain, Cancer
Ottawa: Cardiology
Waterloo: Big Data
London: Imaging
Québec city: Sustainable Health
Laval: Optics
Montréal: AI (Deep Learning),
Brain, medtech)
Boucherville: Diagnostics, nanos
Presented by Diane Côté, CEO of
Big data – The Institute for data
valorization
Scope:
• Machine learning and operational research (25% in
the Health sector)
Expertise:
• More than 1,000 scientists (professors,
professionals and students) with complementary
areas of expertise
• #1 for publications worldwide
• Recognized as “Deep Learning Ground Zero”
Major industrial partners:
Applications of AI in precision medicine:
• Drug development
• Cardiovascular disease risk
stratification and risk management
• Medical and molecular imaging
• Patient empowerment and
partnership
Artifical
Intelligence
Machine
Learning
Deep
Learning
Funding: 93 M$ (public)
Lead: University of Montreal
Presented by Diane Côté, CEO of
Medical Technologies –The TransMedTech Institute
Targeted diseases:
• Musculoskeletal diseases
• Cardiovascular diseases
• Cancers
Strategic Technologies:
• Biosensors & micro medical devices
• Prognostics of progressive pathologies
• Imaging, laser therapies, biophotonic probes
• Nanotechnologies, robotics, theranostics
• Multimodal Imaging, interventional systems
• Minimally invasive devices
• Rehab technologies
Funding: 35 M$ (public)
Lead: Polytechnique Montreal
Presented by Diane Côté, CEO of
Neurosciences – Healthy Brains for Healthy Lives
Scope :
•
•
•
•
Population neuroscience and brain health
Models of neurodegenerative diseases
Cognitive neuroscience of brain plasticity
Neuroinformatics and modelling
CBRAIN-mediated CCC Network
International Partners
Funding: 84 M$ (public)
Lead: McGill
China internal
China-Canada-Cuba
Shenzen Shantou
Presented by Diane Côté, CEO of
Brain Diseases – BrainsCAN: Brain Health for Life
Scope :
• Parkinson
• Alzheimer
• Traumatic brain injury
• Schizophrenia
Goal :
• Deliver evidence-based assessments and interventions for the
diagnosis and treatment of disorders of the brain
Funding: 66 M$ (public)
Lead: Western University
Presented by Diane Côté, CEO of
Sustainable health - Photonics – Sentinel North
Scope :
• Develop innovative tools in opticsphotonics and improve our
understanding of the northern
environment and its impact on human
beings and their health.
• Microbiomes: sentinels of the
northern environment and human
health
• Light-matter and light-organism
interactions to develop intervention
methods (mood control through light)
or approaches and systems to detect
northern sentinels (remote sensing,
biomarker diagnosis/detection).
Funding: 98 M$ (public)
Lead: Laval University
Presented by Diane Côté, CEO of
Pediatric Rehabilitation
Crossroads of open innovation
•
•
•
•
•
Interdisciplinary teams:
Specialized and subspecialized care
Education
Research and Development
Technology Assessment
Clinical-technological platforms
• Science of movement
• Applied Robotics Laboratories in Rehabilitation:
• Lokomat for the rehabilitation of the lower limbs
• Rehabilitation of the upper limbs
• Wheelchair Skills
Learning Specialized laboratories
• Virtual Simulation & Living Lab
• Intelligent materials and FabLab
• Regenerative Medicine and Cell Therapy
Lead: Sainte-Justine University
Teaching Hospital
Presented by Diane Côté, CEO of
Canadian Innovation Catalysts
Presented by Diane Côté, CEO of
Quebec Consortium for Industrial Research and
Innovation in Medical Technology
MEDTEQ is the Quebec Consortium for Industrial Research and Innovation in Medical
Technology. Its mission is to accelerate the development of innovative technological
solutions to improve patients’ health and quality of life. MEDTEQ supports their
validation and integration in the healthcare system and their impact, both locally and
globally, by bringing together the complementary skills of industrial and academic
partners with those of healthcare providers.
Presented by Diane Côté, CEO of
MEDTEQ – A growing medical technology
community
+ 100 members
•
•
•
•
•
•
•
13
56
11
7
6
4
10
Large companies
SMEs
Universities
College Technical Research Centers
Teaching Hospitals
Specialized Research Institutes
Partners
Including :
Specialized Research Institutes
Large Companies
Partners
Teaching Hospitals
College Technical
Research Centers
Universities
SMEs
on MEDTEQ’s Board of Directors
Presented by Diane Côté, CEO of
MEDTEQ - Industrial Members
Presented by Diane Côté, CEO of
MEDTEQ - Universities, Research Centers,
Institutes, Teaching Hospitals and Partners
Presented by Diane Côté, CEO of
MEDTEQ - Innovation Funding Program
• Collaborative Research bringing together industry,
academic researchers, clinicians, professors, students and
more
• New Innovative health technology and processes
• Up to 80% of the Research Project’s budget publicly
financed
• From pre-competitive research to market
• Industry contributions can benefit from leverage of up to
1:7.5
Presented by Diane Côté, CEO of
MEDTEQ – Innovation Focus Areas
STRATEGIC AXES
Connected
health
Imaging
and
Simulation
Human
performance
Personalized
health
Big data
Visualization
Prevention
Diagnosis
Surgical
applications
Sports medicine
ITC
Telehealth
Rehabilitation
Medical training
Custom solution
Neuroscience
Cardiology
Orthopeadics
Enabling technologies
Textiles
BioMEMS
Biomaterials
Plastics/Polymers
Nanotechnology
Presented by Diane Côté, CEO of
MEDTEQ – Technologies of the Future,
Health of tomorrow
Presented by Diane Côté, CEO of
MEDTEQ – Technologies of the Future,
Health of tomorrow
Emovi - KneeKG
Metronic Cryocath - Arctic Front
Kinova - Jaco
Presented by Diane Côté, CEO of
MEDTEQ – Technologies of the Future,
Health of tomorrow
China – Canada
Innovation for Health
Presented by Diane Côté, CEO of